FindTrial
Sign In

The clinical trial of urine methylation test to bladder cancer

The clinical trial of urine methylation test to bladder cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009611
Enrollment
Unknown
Registered
2016-10-26
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

Gold Standard:Histopathological examination
Index test:urine&#32
DNA&#32
methylaiton

Sponsors

Shanghai First people's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 100 Years

Inclusion criteria

Inclusion criteria: Aged > 50 years; gross and microscopy hematuria

Exclusion criteria

Exclusion criteria: No pathological diagnosis

Design outcomes

Primary

MeasureTime frame
the genes number of DNA methylation;—

Countries

China

Contacts

Public ContactXiang Wang

Urology Dept., Shanghai First people's Hospital

seanw_hs@163.com+86 021 64260802

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026